Protalix BioTherapeutics Inc (PLX)
1.15
+0.01
(+0.88%)
USD |
NYAM |
May 08, 16:00
1.15
0.00 (0.00%)
After-Hours: 18:59
Protalix BioTherapeutics Price to Book Value: 2.503 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 2.481 |
| May 06, 2024 | 2.416 |
| May 03, 2024 | 2.481 |
| May 02, 2024 | 2.524 |
| May 01, 2024 | 2.633 |
| April 30, 2024 | 2.481 |
| April 29, 2024 | 2.611 |
| April 26, 2024 | 2.503 |
| April 25, 2024 | 2.568 |
| April 24, 2024 | 2.633 |
| April 23, 2024 | 2.611 |
| April 22, 2024 | 2.568 |
| April 19, 2024 | 2.503 |
| April 18, 2024 | 2.459 |
| April 17, 2024 | 2.503 |
| April 16, 2024 | 2.481 |
| April 15, 2024 | 2.481 |
| April 12, 2024 | 2.568 |
| April 11, 2024 | 2.655 |
| April 10, 2024 | 2.742 |
| April 09, 2024 | 2.873 |
| April 08, 2024 | 2.829 |
| April 05, 2024 | 2.546 |
| April 04, 2024 | 2.633 |
| April 03, 2024 | 2.698 |
| Date | Value |
|---|---|
| April 02, 2024 | 2.698 |
| April 01, 2024 | 2.720 |
| March 28, 2024 | 2.742 |
| March 27, 2024 | 2.720 |
| March 26, 2024 | 2.655 |
| March 25, 2024 | 2.655 |
| March 22, 2024 | 2.764 |
| March 21, 2024 | 2.873 |
| March 20, 2024 | 2.916 |
| March 19, 2024 | 2.829 |
| March 18, 2024 | 2.764 |
| March 15, 2024 | 2.894 |
| March 14, 2024 | 2.981 |
| March 13, 2024 | 3.308 |
| March 12, 2024 | 3.112 |
| March 11, 2024 | 3.134 |
| March 08, 2024 | 3.242 |
| March 07, 2024 | 3.177 |
| March 06, 2024 | 3.221 |
| March 05, 2024 | 3.308 |
| March 04, 2024 | 3.417 |
| March 01, 2024 | 3.525 |
| February 29, 2024 | 3.542 |
| February 28, 2024 | 3.347 |
| February 27, 2024 | 3.390 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.416
Minimum
May 06 2024
284.46
Maximum
Sep 30 2021
56.58
Average
7.009
Median
Jun 14 2021
Price to Book Value Benchmarks
| Agenus Inc | -- |
| InfuSystems Holdings Inc | 3.240 |
| AIM ImmunoTech Inc | 2.198 |
| Perspective Therapeutics Inc | 13.66 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 57.50 |
| PS Ratio | 1.365 |
| Price | 1.15 |
| Earnings Yield | 1.74% |
| Market Cap | 84.01M |
| Operating PE Ratio | 8.549 |
| Normalized PE Ratio | 57.50 |